Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan;58(1):61-4.
doi: 10.4103/0019-5154.105311.

Relevant issues in pharmacotherapy of psycho-cutaneous disorders

Affiliations

Relevant issues in pharmacotherapy of psycho-cutaneous disorders

Sreyoshi Ghosh et al. Indian J Dermatol. 2013 Jan.

Abstract

Psychiatric disorders frequently co-occur with dermatological conditions and psychotropic agents may be indicated in treating the underlying psychiatric symptoms. Use of psychotropics can be associated with significant cutaneous adverse effects as well as drug interactions with pharmacological agents used in treatment of the dermatological conditions. Knowledge of indication, contraindication, side effects, and interactions of psycho-tropics is essential for the practicing dermatologist in managing psycho-dermatological conditions. This review aims at discussing relevant issues in pharmacological management of psycho-cutaneous disorders.

Keywords: Pharmacotherapy; psychodermatology; psychotropics.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil.

Similar articles

Cited by

References

    1. Rosenheck R, Perlick D, Bingham S, Liu-Mares W, Collins J, Warren S, et al. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: A randomized controlled trial. JAMA. 2003;290:2693–702. - PubMed
    1. Gautam S, Meena PS. Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics. Indian J Psychiatry. 2011;53:128–33. - PMC - PubMed
    1. Srinivasan TN, Suresh TR, Jayaram V, Fernandez MP. Nature and treatment of delusional parasitosis: A different experience in India. Int J Dermatol. 1994;33:851–5. - PubMed
    1. Damiani JT, Flowers FP, Pierce DK. Pimozide in delusions of parasitosis. J Am Acad Dermatol. 1990;22:312. - PubMed
    1. Safer DL, Wenegrat B, Roth WT. Risperidone in the Treatment of Delusional Parasitosis: A Case Report. J Clin Psychopharmacol. 1994;17:131–2. - PubMed
-